Fayon M, Martinez-Cingolani C, Abecassis A, Roders N, Nelson E, Choisy C, Talbot A, Bensussan A, Fermand J-P, Arnulf B, Bories J-C. Bi38-3 is a novel CD38/CD3 bispecific T-cell engager with low toxicity for the treatment of multiple myeloma. Haematologica [Internet]. 2021Apr.1 [cited 2026Nov.10];106(4):1193-7. Available from: https://haematologica.org/article/view/9809